A NOVEL TRP2 ISOFORM CONTAINING HLA-A2 RESTRICTED CYTOTOXIC T LYMPHOCYTE EPITOPES

Details for Australian Patent Application No. 2002336244 (hide)

Owner THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALT

Inventors KHONG, Hung; ROSENBERG, Steven, A.

Pub. Number AU-A-2002336244

PCT Number PCT/US02/07698

PCT Pub. Number WO2002/074788

Priority 60/277,108 19.03.01 US

Filing date 15 March 2002

Wipo publication date 3 October 2002

Event Publications

20 February 2003 Complete Application Filed

  Priority application(s): 60/277,108 19.03.01 US

27 March 2003 Application Open to Public Inspection

  Published as AU-A-2002336244

19 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002336245-Hormone replacement therapy

2002336243-METHOD AND APPARATUS FOR COATING SKIN PIERCING MICROPROJECTIONS